CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,039,407 | -44.5% | 143,700 | -46.7% | 0.03% | -44.3% |
Q2 2022 | $7,273,754 | +111.5% | 269,798 | +167.3% | 0.06% | +190.5% |
Q1 2022 | $3,438,357 | -38.6% | 100,950 | -30.4% | 0.02% | -36.4% |
Q4 2021 | $5,602,800 | +332.4% | 145,000 | +504.2% | 0.03% | +266.7% |
Q3 2021 | $1,295,760 | -52.6% | 24,000 | -81.9% | 0.01% | -62.5% |
Q1 2021 | $2,732,323 | +816.9% | 132,637 | +559.9% | 0.02% | +700.0% |
Q3 2020 | $298,000 | – | 20,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |